195 related articles for article (PubMed ID: 24145993)
1. Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients.
Langer I; Guller U; Worni M; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Viehl C; Bronz L; Schnarwyler B; Wight E; Infanger E; Burger D; Koechli OR; Zuber M;
Ann Surg Oncol; 2014 Feb; 21(2):401-7. PubMed ID: 24145993
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
4. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
[TBL] [Abstract][Full Text] [Related]
8. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
9. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
11. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
12. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
[TBL] [Abstract][Full Text] [Related]
13. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
14. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
16. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast.
Creager AJ; Geisinger KR; Perrier ND; Shen P; Shaw JA; Young PR; Case D; Levine EA
Ann Surg; 2004 Jan; 239(1):61-6. PubMed ID: 14685101
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer.
Rovera F; Fachinetti A; Rausei S; Chiappa C; Lavazza M; Arlant V; Marelli M; Boni L; Dionigi G; Dionigi R
Int J Surg; 2013; 11 Suppl 1():S73-8. PubMed ID: 24380559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
